BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35691247)

  • 1. The role of A-kinase interacting protein 1 in regulating progression and stemness as well as indicating the prognosis in glioblastoma.
    Tang J; Peng S; Yan H; Ni M; Hou X; Ma P; Li Y
    Transl Oncol; 2022 Aug; 22():101463. PubMed ID: 35691247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AKIP1 promotes glioblastoma viability, mobility and chemoradiation resistance via regulating CXCL1 and CXCL8 mediated NF-κB and AKT pathways.
    Han D; Zhang N; Zhao S; Liu H; Wang X; Yang M; Wang S; Li Y; Liu Z; Teng L
    Am J Cancer Res; 2021; 11(4):1185-1205. PubMed ID: 33948353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A-Kinase Interacting Protein 1 Promotes Cell Invasion and Stemness
    Luo Z; Luo Y; Xiao K
    Front Oncol; 2021; 11():798557. PubMed ID: 35355804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AKIP1 accelerates glioblastoma progression through stabilizing EGFR expression.
    Wan S; Liu C; Li C; Wang Z; Zhao G; Li J; Ran W; Zhong X; Li Y; Zhang L; Cui H
    Oncogene; 2023 Sep; 42(39):2905-2918. PubMed ID: 37596322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A-Kinase Interacting Protein 1 Knockdown Restores Chemosensitivity
    Zheng H; Lin Q; Rao Y
    Front Oncol; 2022; 12():854702. PubMed ID: 35965570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A-kinase-interacting protein 1 promotes EMT and metastasis via PI3K/Akt/IKKβ pathway in cervical cancer.
    Zhang X; Liu S; Zhu Y
    Cell Biochem Funct; 2020 Aug; 38(6):782-791. PubMed ID: 32401379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A-kinase-interacting protein 1 overexpression correlates with deteriorative tumor features and worse survival profiles, and promotes cell proliferation but represses apoptosis in non-small-cell lung cancer.
    Chen H; Yan S; Dong L; Li X
    J Clin Lab Anal; 2020 Feb; 34(2):e23061. PubMed ID: 31828834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A-kinase interacting protein 1 regulates the cell proliferation, invasion, migration and angiogenesis of clear cell renal cell carcinoma cells and affects the ERK/c-Myc signaling pathway by binding to Rac1.
    Zhang Y; Zhang H; Han Z; Wang X; Li X; Yuan P; Ji S; Liu Q
    Exp Ther Med; 2022 Sep; 24(3):558. PubMed ID: 35978938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AKIP1 promotes tumor progression by cancer-related pathways and predicts prognosis in tongue squamous cell carcinoma.
    Wang N; Bai D; Kristiansen E; Deng R; Zhang S
    Am J Transl Res; 2021; 13(11):12338-12351. PubMed ID: 34956456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A-kinase-interacting protein 1 facilitates growth and metastasis of gastric cancer cells via Slug-induced epithelial-mesenchymal transition.
    Chen D; Cao G; Liu Q
    J Cell Mol Med; 2019 Jun; 23(6):4434-4442. PubMed ID: 31020809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
    Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
    J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of glycosyltransferase PomGnT1 in glioblastoma progression.
    Lan J; Guo P; Lin Y; Mao Q; Guo L; Ge J; Li X; Jiang J; Lin X; Qiu Y
    Neuro Oncol; 2015 Feb; 17(2):211-22. PubMed ID: 25085363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
    Guan Y; He Y; Lv S; Hou X; Li L; Song J
    J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crosstalk between PI3K/AKT/mTOR and WNT/β-Catenin signaling in GBM - Could combination therapy checkmate the collusion?
    Daisy Precilla S; Biswas I; Kuduvalli SS; Anitha TS
    Cell Signal; 2022 Jul; 95():110350. PubMed ID: 35525406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRPM7 Induces Tumorigenesis and Stemness Through Notch Activation in Glioma.
    Wan J; Guo AA; King P; Guo S; Saafir T; Jiang Y; Liu M
    Front Pharmacol; 2020; 11():590723. PubMed ID: 33381038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of glioblastoma multiforme using a combination of small interfering RNA targeting epidermal growth factor receptor and β-catenin.
    Wang K; Park JO; Zhang M
    J Gene Med; 2013 Jan; 15(1):42-50. PubMed ID: 23319157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of AKIP1 predicts poor prognosis of patients with breast carcinoma and promotes cancer metastasis through Akt/GSK-3β/Snail pathway.
    Mo D; Li X; Li C; Liang J; Zeng T; Su N; Jiang Q; Huang J
    Am J Transl Res; 2016; 8(11):4951-4959. PubMed ID: 27904695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3BDO inhibits the proliferation, epithelial-mesenchymal transition (EMT), and stemness via suppressing survivin in human glioblastoma cells.
    Wang Z; Li Y; Liu M; Chen D; Lu J; Ji Y; Xing Z; Wang Y
    J Cancer; 2022; 13(4):1203-1213. PubMed ID: 35281871
    [No Abstract]   [Full Text] [Related]  

  • 19. Multiple lesions in receptor tyrosine kinase pathway determine glioblastoma response to pan-ERBB inhibitor PF-00299804 and PI3K/mTOR dual inhibitor PF-05212384.
    Zhu Y; Shah K
    Cancer Biol Ther; 2014 Jun; 15(6):815-22. PubMed ID: 24658109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIF1α/HIF2α-Sox2/Klf4 promotes the malignant progression of glioblastoma via the EGFR-PI3K/AKT signalling pathway with positive feedback under hypoxia.
    Wang P; Zhao L; Gong S; Xiong S; Wang J; Zou D; Pan J; Deng Y; Yan Q; Wu N; Liao B
    Cell Death Dis; 2021 Mar; 12(4):312. PubMed ID: 33762574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.